Integrated BioBank of Luxembourg (IBBL)

Core business

IBBL (Integrated BioBank of Luxembourg) is an autonomous not-for-profit institute dedicated to supporting biomedical research for the benefit of patients. IBBL is an integrated research infrastructure offering bioservices, including the collection, processing, analysis and storage of biological samples and associated data. In addition, IBBL carries out research to optimise biospecimen processing and certify biospecimen quality. IBBL is ISO 9001:2015 certified and ISO 17025:2005 accredited, and its quality management system is conceived to be compliant with NF S96-900:2011 and ISO 17043:2010. IBBL’s mission is to provide biospecimen related services and a biobanking infrastructure for applied medical research. IBBL’s vision is to be an international centre of excellence in biobanking and a valued partner in developing better healthcare solutions. IBBL is an autonomous institute, organised within the Luxembourg Institute of Health (LIH).

Products & services

We offer a complete range of well-established, standardised services to academia, EU consortia and industry, based on our 10 years of proven experience. Our service offer is characterised by a breadth of optimised, validated and published processes – ranging from aliquoting of liquid biopsies to tissue processing and cell culture – giving our clients full flexibility to choose the services that best suit their needs. Our service offer includes:

• Biobanking
• Sample processing
• Sample analysis and quality control
• Biomarker validation
• Biospecimen Proficiency Testing
• University Biobanking Certificate

Major HealthTech projects

We are firmly invested in supporting research that will advance the introduction of personalised medicine for the benefit of patients and we have decided to make cancer, diabetes, the general population, microbiome, Parkinson’s disease and biospecimen research a priority. Most of our national projects are run under the umbrella of the Personalised Medicine Consortium (PMC). Led by a principle investigator from a research institute or hospital, these projects focus on investigating disease mechanisms, diagnostics, or novel treatments. We are proud to be part of several large-scale national projects, including the National Centre of Excellence in Research on Parkinson’s disease (NCER-PD) and the National Cancer Plan. At the European level, we joined the consortia of numerous projects funded through initiatives such as the Joint Programme in Neurodegenerative Disease Research (JPND), FP7, Horizon2020 and the Innovative Medicines Initiative – IMI.

Main customers / collaborations

We work with a great number of public and private sector partners. Collaborations and partner networks allow us to work more efficiently, learn from our colleagues and share information, knowledge and experiences. Our approach to partnering is to be open, flexible and adaptable. Within partnership, our role can range from straightforward sub-contracting to research leadership, depending on our partners’ needs. We collaborate with organisations and individuals on biospecimen collection projects, research, industrial projects, and provide samples and services to our clients.